[Use of lysozyme and prodigiozan in the treatment of suppurative infections in diabetics].
The natural resistance of the organism studied in 152 patients with purulent surgical infections against the background of diabetes mellitus was found to be considerably changed. Prodigiozan included in the complex measures of treatment was shown by the author to result in positive dynamics of the indices of humoral defense of the organism, in shortening the terms of treatment in the hospital by 5,2 days on the average. The most pronounced influence on the natural immunity factors and better postoperative results were found following joint employment of lysozyme and prodigiozan. The hospital treatment of this group of patients was 7.3 days shorter.
D000368:Aged; D001424:Bacterial Infections / Q000150:complications / Q000276:immunology / Q000628:therapy*; D001770:Blood Bactericidal Activity; D003131:Combined Modality Therapy; D048909:Diabetes Complications; D004359:Drug Therapy, Combination; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D008875:Middle Aged; D009113:Muramidase / Q000627:therapeutic use*; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D011354:Prodigiozan / Q000627:therapeutic use*; D013492:Suppuration
D007136:Immunoglobulins; D011135:Polysaccharides, Bacterial; D011354:Prodigiozan; D009113:Muramidase
Primenenie lizotsima i prodigiozana pri lechenii gnoĭnoĭ infektsii u bol'nykh sakharnym diabetom.